Clinical Trial: A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07456033) titled 'A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma' on March 02.

Brief Summary: The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

Study Start Date: March 06

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: Depemokimab

Depemokimab will be administered

DRUG: Placebo

Placebo will be administered

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmithKline

Publishe...